These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22579434)

  • 1. An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
    Merenstein D; Wang C; Gandhi M; Robison E; Levine AM; Schwartz RM; Weber KM; Liu C
    Complement Ther Med; 2012 Aug; 20(4):222-7. PubMed ID: 22579434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term garlic supplementation and highly active antiretroviral treatment adherence, CD4+ cell counts, and human immunodeficiency virus viral load.
    Liu C; Wang C; Robison E; Levine AM; Gandhi M; Schwartz R; Weber KM; Merenstein D
    Altern Ther Health Med; 2012; 18(1):18-22. PubMed ID: 22516847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States.
    Dale S; Cohen M; Weber K; Cruise R; Kelso G; Brody L
    AIDS Patient Care STDS; 2014 Mar; 28(3):136-43. PubMed ID: 24568654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.
    Aziz M; Livak B; Burke-Miller J; French AL; Glesby MJ; Sharma A; Young M; Villacres MC; Tien PC; Golub ET; Cohen MH; Adeyemi OM
    AIDS; 2013 Feb; 27(4):573-8. PubMed ID: 23095316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.
    Berhane K; Karim R; Cohen MH; Masri-Lavine L; Young M; Anastos K; Augenbraun M; Watts DH; Levine AM
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1245-52. PubMed ID: 15385731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
    Merenstein D; Schneider MF; Cox C; Schwartz R; Weber K; Robison E; Gandhi M; Richardson J; Plankey MW
    AIDS Patient Care STDS; 2009 Apr; 23(4):289-96. PubMed ID: 19243274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high-dose vs standard-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial.
    Isanaka S; Mugusi F; Hawkins C; Spiegelman D; Okuma J; Aboud S; Guerino C; Fawzi WW
    JAMA; 2012 Oct; 308(15):1535-44. PubMed ID: 23073950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).
    Navazesh M; Mulligan R; Karim R; Mack WJ; Ram S; Seirawan H; Greenspan J; Greenspan D; Phelan J; Alves M;
    Oral Dis; 2009 Jan; 15(1):52-60. PubMed ID: 19017280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients.
    Horberg MA; Silverberg MJ; Hurley LB; Towner WJ; Klein DB; Bersoff-Matcha S; Weinberg WG; Antoniskis D; Mogyoros M; Dodge WT; Dobrinich R; Quesenberry CP; Kovach DA
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):384-90. PubMed ID: 18091609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).
    Seyoum A; Ndlovu P; Temesgen Z
    AIDS Res Ther; 2017 Mar; 14(1):14. PubMed ID: 28302125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
    Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
    AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.
    Silverberg MJ; Gore ME; French AL; Gandhi M; Glesby MJ; Kovacs A; Wilson TE; Young MA; Gange SJ
    Clin Infect Dis; 2004 Sep; 39(5):717-24. PubMed ID: 15356788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy.
    Li X; Margolick JB; Jamieson BD; Rinaldo CR; Phair JP; Jacobson LP
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):421-8. PubMed ID: 21602699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of traditional Chinese medicine on CD4 + T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy].
    Zhao HX; Zhang FJ; Han N; Lan MD; Yao J; Liu ZY; Lu LH; Wei HS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):658-61. PubMed ID: 17121226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.